Evidence map›Paper›PMID 39456452›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Facile One-Pot Conversion of (poly)phenols to Diverse (hetero)aryl Compounds by Suzuki Coupling Reaction: A Modified Approach for the Synthesis of Coumarin- and Equol-Based Compounds as Potential Antioxidants.

Muthipeedika Nibin Joy, Igor S Kovalev, Olga V Shabunina, Sougata Santra, Grigory V Zyryanov

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muthipeedika Nibin JoyUral Federal University named after the first President of Russia B. N. Yeltsin, 19 Mira Street, Yekaterinburg 620002, Russia.ORCID 0000-0002-9912-2264
Igor S KovalevUral Federal University named after the first President of Russia B. N. Yeltsin, 19 Mira Street, Yekaterinburg 620002, Russia.ORCID 0000-0002-0537-3274
Olga V ShabuninaUral Federal University named after the first President of Russia B. N. Yeltsin, 19 Mira Street, Yekaterinburg 620002, Russia.
Sougata SantraUral Federal University named after the first President of Russia B. N. Yeltsin, 19 Mira Street, Yekaterinburg 620002, Russia.
Grigory V ZyryanovUral Federal University named after the first President of Russia B. N. Yeltsin, 19 Mira Street, Yekaterinburg 620002, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation Reference # 075-15-2022-1118, dated 29 June 2022Russian Science Foundation Grant # 24-23-00516
6 · The paper itself

Abstract

A series of 16 (hetero)aryl compounds based on coumarin and equol has been efficiently synthesized by exploring the palladium-catalyzed Suzuki cross-coupling reactions. Polyphenol based on coumarin (4-methyl-7-hydroxy coumarin) was initially converted to corresponding coumarin imidazylate and then subjected to Suzuki coupling reaction with 4-methoxyphenylboronic acid to obtain the coupled product. This modified approach was later developed into a one-pot methodology by directly reacting the polyphenol with 1,1-sulfonyldiimidazole (SDI) and boronic acid in situ to obtain the Suzuki coupled product in one step. Moreover, an array of (poly)phenols based on coumarin and equol were later converted to diverse (hetero)aryl compounds by this optimized step-economic protocol. The synthesized compounds were then subjected to the screening of their potential antioxidant activities by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. In our investigation, the compounds

Indexed as

antioxidantsaryl imidazylatescoumarinDPPHSuzuki coupling

Identifiers

PMID39456452
PMCPMC11504026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.